INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, INSTITUT REGIONAL DU CANCER DE MONTPELLIER, UNIVERSITE DE MONTPELLIER FILES APPLICATION FOR "INHIBITOR OF THE FLAVIN-CONTAINING MONOOXYGENASE (FMO) FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Sept. 1 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), INSTITUT REGIONAL DU CANCER DE MONTPELLIER (208, Rue Des Apothicaires - Parc Euromedecine34298 Montpellier), UNIVERSITE DE MONTPELLIER (163, rue Auguste Broussonnet34090 Montpellier) filed a patent application (PCT/EP2025/054358) for "INHIBITOR OF THE FLAVIN-CONTAINING MONOOXYGENASE (FMO) FOR USE IN THE TREATMENT OF CANCER" on Feb 18, 2025. With publication no. WO/2025/176679, the details related to the patent application was published on Aug 28, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

I...